Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 12.2x - 13.4x | 12.8x |
| Selected Fwd EBIT Multiple | 9.0x - 10.0x | 9.5x |
| Fair Value | €12.92 - €16.42 | €14.67 |
| Upside | 8.6% - 38.0% | 23.3% |
| Benchmarks | Ticker | Full Ticker |
| CompuGroup Medical SE & Co. KGaA | COP | DB:COP |
| Median Technologies SA | ALMDT | ENXTPA:ALMDT |
| Intrasense S.A. | ALINS | ENXTPA:ALINS |
| Physitrack PLC | PTRK | OM:PTRK |
| Vidavo S.A. | VIDAVO | ATSE:VIDAVO |
| Cegedim SA | C7E | DB:C7E |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| COP | ALMDT | ALINS | PTRK | VIDAVO | C7E | ||
| DB:COP | ENXTPA:ALMDT | ENXTPA:ALINS | OM:PTRK | ATSE:VIDAVO | DB:C7E | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | -3.3% | NM- | NM- | NM- | NM- | 1.7% | |
| 3Y CAGR | -2.8% | NM- | NM- | NM- | 12.0% | 0.9% | |
| Latest Twelve Months | -31.6% | -7.2% | -60.1% | -258.1% | 376.1% | 26.1% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 10.3% | -83.5% | -78.3% | 6.5% | 15.1% | 6.2% | |
| Prior Fiscal Year | 10.0% | -97.5% | -106.1% | -1.0% | -10.4% | 4.8% | |
| Latest Fiscal Year | 8.3% | -101.5% | -249.9% | -3.2% | 22.1% | 5.7% | |
| Latest Twelve Months | 7.2% | -113.0% | -249.9% | -3.2% | 15.4% | 5.7% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.62x | 2.74x | 6.89x | 1.42x | 2.57x | 0.68x | |
| EV / LTM EBITDA | 13.1x | -2.5x | -2.8x | 6.1x | 16.5x | 4.2x | |
| EV / LTM EBIT | 19.6x | -2.4x | -2.8x | -44.7x | 16.7x | 11.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -44.7x | -2.4x | 19.6x | ||||
| Historical EV / LTM EBIT | 11.8x | 15.8x | 17.2x | ||||
| Selected EV / LTM EBIT | 12.2x | 12.8x | 13.4x | ||||
| (x) LTM EBIT | 38 | 38 | 38 | ||||
| (=) Implied Enterprise Value | 458 | 482 | 506 | ||||
| (-) Non-shareholder Claims * | (279) | (279) | (279) | ||||
| (=) Equity Value | 178 | 203 | 227 | ||||
| (/) Shares Outstanding | 13.7 | 13.7 | 13.7 | ||||
| Implied Value Range | 13.02 | 14.77 | 16.53 | ||||
| FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 13.02 | 14.77 | 16.53 | 11.90 | |||
| Upside / (Downside) | 9.4% | 24.1% | 38.9% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | COP | ALMDT | ALINS | PTRK | VIDAVO | C7E | |
| Enterprise Value | 1,136 | 61 | 15 | 23 | 4 | 442 | |
| (+) Cash & Short Term Investments | 0 | 16 | 1 | 1 | 0 | 50 | |
| (+) Investments & Other | 0 | 0 | 0 | 0 | 0 | 15 | |
| (-) Debt | 0 | (32) | (1) | (5) | (0) | (326) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | (18) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 1,136 | 46 | 15 | 19 | 4 | 163 | |
| (/) Shares Outstanding | 51.7 | 19.0 | 52.6 | 16.3 | 0.9 | 13.7 | |
| Implied Stock Price | 21.96 | 2.40 | 0.29 | 1.17 | 4.64 | 11.90 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 0.09 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 21.96 | 2.40 | 0.29 | 12.90 | 4.64 | 11.90 | |
| Trading Currency | EUR | EUR | EUR | SEK | EUR | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 0.09 | 1.00 | 1.00 | |